Advanced Search

Tyrosine Kinase Stocks List

Symbol Grade Name % Change
EXEL C Exelixis, Inc. 0.67
EYPT B EyePoint Pharmaceuticals, Inc. 4.23
RIGL D Rigel Pharmaceuticals, Inc. 0.87
PBYI F Puma Biotechnology Inc -1.73
KIN C Kindred Biosciences, Inc. -4.32
BPMC F Blueprint Medicines Corporation -0.13
KALA F Kala Pharmaceuticals, Inc. -7.75
COGT D Cogent Biosciences, Inc. 0.99
BBIO D BridgeBio Pharma, Inc. -1.96
RLAY F Relay Therapeutics, Inc. -1.14
NRIX F Nurix Therapeutics, Inc. -11.86
KRON D Kronos Bio, Inc. 1.36
ANGN F Angion Biomedica Corp. -3.42
View As Page of Charts
Related Industries: Biotechnology Other
Related Stock Lists: Cancer Biopharmaceutical Protein Kinase Inhibitor Biotechnology Enzymes Tyrosine Kinase Receptors Fibroblast Growth Factor Receptor Gastrointestinal Inflammation Medicine Ophthalmic Receptor Tyrosine Kinase Autoimmune Disease Autoimmune Diseases Bruton Chemical Compounds Daiichi Sankyo Eye Gastrointestinal Stromal Tumor Glucocorticoids

Related ETFs - A few ETFs which own one or more of the above listed Tyrosine Kinase stocks.

Symbol Grade Name Weight
IDNA C iShares Genomics Immunology and Healthcare ETF 8.56
IBBJ F Defiance Nasdaq Junior Biotechnology ETF 4.95
LABD D Direxion Daily S&P Biotech Bear 3X Shares 4.46
BBP D BioShares Biotechnology Products Fund 4.3
XBI F SPDR Series Trust SPDR S&P Biotech ETF 3.88
View all Tyrosine Kinase related ETFs...
Compare ETFs
  • Compare IDNA to BBP
  • Compare LABD to BBP
  • Compare LABD to XBI

    • Recent Signals

    Date Stock Signal Type
    2021-05-05 ANGN 20 DMA Resistance Bearish
    2021-05-05 BPMC Stochastic Reached Oversold Weakness
    2021-05-05 COGT Bollinger Band Squeeze Range Contraction
    2021-05-05 COGT 50 DMA Resistance Bearish
    2021-05-05 EXEL 20 DMA Resistance Bearish
    2021-05-05 EXEL Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
    2021-05-05 EXEL Pocket Pivot Bullish Swing Setup
    2021-05-05 EYPT Crossed Above 50 DMA Bullish
    2021-05-05 EYPT Expansion Pivot Buy Setup Bullish Swing Setup
    2021-05-05 KALA New 52 Week Closing Low Bearish
    2021-05-05 KALA Stochastic Reached Oversold Weakness
    2021-05-05 KALA Lower Bollinger Band Walk Weakness
    2021-05-05 KALA New 52 Week Low Weakness
    2021-05-05 KIN MACD Bearish Centerline Cross Bearish
    2021-05-05 KIN MACD Bearish Signal Line Cross Bearish
    2021-05-05 KIN 20 DMA Resistance Bearish
    2021-05-05 KIN Fell Below 50 DMA Bearish
    2021-05-05 KRON Shooting Star Candlestick Bearish
    2021-05-05 KRON 50 DMA Resistance Bearish
    2021-05-05 KRON Stochastic Sell Signal Bearish
    2021-05-05 KRON Lizard Bearish Bearish Day Trade Setup
    2021-05-05 NRIX MACD Bearish Centerline Cross Bearish
    2021-05-05 NRIX Fell Below 20 DMA Bearish
    2021-05-05 PBYI MACD Bearish Signal Line Cross Bearish
    2021-05-05 PBYI 20 DMA Resistance Bearish
    2021-05-05 PBYI Bollinger Band Squeeze Range Contraction
    2021-05-05 RIGL NR7 Range Contraction
    2021-05-05 RIGL Doji - Bullish? Reversal
    2021-05-05 RIGL MACD Bearish Signal Line Cross Bearish
    2021-05-05 RLAY Bollinger Band Squeeze Range Contraction
    2021-05-05 RLAY Stochastic Reached Oversold Weakness
    2021-05-05 RLAY New 52 Week Closing Low Bearish
    2021-05-05 RLAY Spinning Top Other

    Recent News for Tyrosine Kinase Stocks

    Date Stock Title
    May 5 RIGL Rigel Pharmaceuticals, Inc. 2021 Q1 - Results - Earnings Call Presentation
    May 5 EXEL Exelixis Q1 Earnings Preview
    May 5 RIGL Rigel Pharmaceuticals EPS beats by $0.26, beats on revenue
    May 5 RIGL Rigel Reports First Quarter 2021 Financial Results and Provides Business Update
    May 5 EYPT EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q1 2021 Results - Earnings Call Transcript
    May 5 KALA Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2021 Results - Earnings Call Transcript
    May 5 EYPT EyePoint Pharmaceuticals (EYPT) Reports Q1 Loss, Misses Revenue Estimates
    May 5 KALA Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates
    May 5 EYPT EyePoint Pharmaceuticals EPS beats by $0.01, misses on revenue
    May 5 KALA Kala Pharmaceuticals EPS misses by $0.01, misses on revenue
    May 5 KALA Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
    May 5 EYPT EyePoint Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Corporate Developments
    May 5 RLAY Relay Therapeutics to Participate in Fireside Chat at Bank of America 2021 Health Care Conference
    May 5 RIGL Earnings Scheduled For May 5, 2021
    May 4 EXEL Exelixis Expands its Biotherapeutics Portfolio with Acquisition of GamaMabs Pharma’s First-in-Class Humanized Antibody Program Against a Novel Oncology Target
    May 3 BBIO BridgeBio Pharma Stock Forecast: A Long-Term Buy Or Sell
    May 3 COGT Cogent Biosciences names new chief legal officer
    May 3 KIN Kindred Biosciences to Announce First Quarter 2021 Financial Results
    May 3 BBIO SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BridgeBio Pharma, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
    May 3 COGT Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer
    Related Industries: Biotechnology Other
    Related Stock Lists: Cancer Biopharmaceutical Protein Kinase Inhibitor Biotechnology Enzymes Tyrosine Kinase Receptors Fibroblast Growth Factor Receptor Gastrointestinal Inflammation Medicine Ophthalmic Receptor Tyrosine Kinase Autoimmune Disease Autoimmune Diseases Bruton Chemical Compounds Daiichi Sankyo Eye Gastrointestinal Stromal Tumor Glucocorticoids

    Browse All Tags